Drug patents revoked in 2018
Drug patents revoked in 2018 at the European Patent Office (EPO)
| Patent Number | Patent Title | Company | Revoked Date | Oppositions |
|---|---|---|---|---|
| EP2181696B1 | Anti-Spot Skin Treatment | HENKEL AG AND CO KGAA |
Dec, 2018
|
BEIERSDORF
LOREAL DIPI
|
| EP2499914B1 | Antiseptic Solutions Comprising Chlorhexidine Or Its Salt And An Anionic Dye And Their Preparation | MEDICHEM SA |
Nov, 2018
|
LAIR LIQUIDE
|
| EP2637664B1 | Compositions And Methods Of Treating Pulmonary Hypertension | GILEAD SCIENCES INC |
Nov, 2018
|
ALFRED E TIEFENBACHER
GENERICS UK
SANDOZ
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
ZENTIVA GROUP
|
| EP2484696B1 | Antagonistic Hlight-Specific Human Monoclonal Antibodies | KYOWA HAKKO KIRIN CO LTD |
Nov, 2018
|
EUROPEAN OPPOSITIONS
|
| EP2519231B1 | Treatment Of Disease With Proteasome Inhibitors Background Of The Invention | JANSSEN PHARMACEUTICA NV |
Oct, 2018
|
ACCORD HEALTHCARE
|
| EP2575803B1 | Methods Of Treating Bladder Cancer | ABRAXIS BIOSCIENCE LLC |
Sep, 2018
|
GENERICS UK
|
| EP2783686B1 | Combination Of A Rapamycin Derivative And Letrozole For Treating Breast Cancer | NOVARTIS AG |
Aug, 2018
|
GENERICS UK
|
| EP2223687B1 | (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions Thereof | CELGENE CORP |
Aug, 2018
|
ZAKLADY FARMACEUTYCZNE POLPHARMA
|
| EP1742958B1 | Methods And Compositions For The Specific Inhibition Of Gene Expression By Double-Stranded Rna | INTEGRATED DNA TECHNOLOGIES INC |
Aug, 2018
|
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
|
| EP2957278B1 | A Stable Composition Comprising Pthrp And Uses Thereof | IPSEN PHARMA SAS |
Jul, 2018
|
ISENBRUCK BSL HRSCHLER
TEVA PHARMACEUTICAL INDUSTRIES
|
| EP2338571B1 | Agent For Colouring And/Or Bleaching Keratinous Fibres In Two Parts, Including A Particular Fatty Body And A Reductone | LOREAL SA |
Jul, 2018
|
HENKEL
|
| EP2448548B1 | Methods For Improving The Appearance Of Hyperpigmented Spot(S) With Multiple Actives | PROCTER AND GAMBLE CO |
May, 2018
|
UNILEVER
|